Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01853631
Title Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Baylor College of Medicine
Indications

B-cell lymphoma

chronic lymphocytic leukemia

B-cell acute lymphoblastic leukemia

Therapies

Anti-CD19 CAR T cells

Cyclophosphamide + Fludarabine

Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.